Outcomes of ICSI in a Study Comparing HP hMG and r-hFSH Video

Solutions-focused therapy improves mental health in IVF patients

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Low antimüllerian hormone levels linked to reduced odds of conception

A recent study found that a solution-focused approach significantly enhances mental well-being, sleep quality, and reproductive health in women of advanced maternal age undergoing in vitro fertilization.

February 5th 2025

Fresh embryo transfer boosts IVF success for low-prognosis women

In a recent study, patients of all age categories were less likely to conceive if they had low antimüllerian hormone levels, highlighting its potential in reproductive counseling.

February 4th 2025

FDA grants clearance for phase 3 trial of Fertilo, an iPSC-based fertility treatment

A new study suggests that fresh embryo transfer may improve live birth rates in women with a low chance of in vitro fertilization success compared to frozen embryo transfer.

Gameto's Fertilo investigational product made of ovarian support cells (OSCs) in a vial. Photo credit: Gameto

Morgan Ebert, Managing Editor

January 30th 2025

Contemporary OB/GYN week in review: Contraceptive trends, STI assay, and more

Gameto’s Fertilo gets FDA clearance for a phase 3 trial, pioneering iPSC-based fertility treatment to shorten IVF cycles and improve reproductive care.

January 24th 2025

Contemporary OB/GYN week in review: Chronic pain, abortion laws, and more

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Related Content

Infertility

Solutions-focused therapy improves mental health in IVF patients

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Low antimüllerian hormone levels linked to reduced odds of conception

February 5th 2025

Fresh embryo transfer boosts IVF success for low-prognosis women

In a recent study, patients of all age categories were less likely to conceive if they had low antimüllerian hormone levels, highlighting its potential in reproductive counseling.

February 4th 2025

FDA grants clearance for phase 3 trial of Fertilo, an iPSC-based fertility treatment

A new study suggests that fresh embryo transfer may improve live birth rates in women with a low chance of in vitro fertilization success compared to frozen embryo transfer.

Morgan Ebert, Managing Editor

January 30th 2025

Contemporary OB/GYN week in review: Contraceptive trends, STI assay, and more

Gameto’s Fertilo gets FDA clearance for a phase 3 trial, pioneering iPSC-based fertility treatment to shorten IVF cycles and improve reproductive care.

January 24th 2025